Interview with CEO Nils Brünner in BioStock

BioStock has intervied CEO Nils Brünner. The interview gives a short and and very easy-to-read overview of the status in Scandion Oncology. Some of the themes are a short background, patent situation and business potential. The interview can be read here: https://www.biostock.se/2019/11/scandion-oncology-ceo-sco-101-promises-blockbuster-potential/

 

 

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union